Association of Ibrutinib Treatment With Bleeding Complications in Cutaneous Surgery

JAMA Dermatol. 2017 Oct 1;153(10):1069-1070. doi: 10.1001/jamadermatol.2017.1877.

Authors

Cindy E Parra¹, Emily Newsom², Erica H Lee³, John N Allan⁴, Kira Minkis²

Affiliations

¹ Weill Cornell Medical College, New York, New York.
² Department of Dermatology, Weill Cornell/New York Presbyterian, New York, New York.
³ Dermatology Division, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell/New York Presbyterian, New York, New York.

PMID: 28700792
DOI: 10.1001/jamadermatol.2017.1877

No abstract available

Publication types

Case Reports

MeSH terms

Adenine / analogs & derivatives
Aged
Aged, 80 and over
Humans
Male
Mohs Surgery / adverse effects*
Piperidines
Postoperative Hemorrhage / chemically induced*
Postoperative Hemorrhage / diagnosis
Pyrazoles / adverse effects*
Pyrimidines / adverse effects*
Risk Factors
Skin Neoplasms / drug therapy*
Skin Neoplasms / surgery

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine